axon-lawyers documents

Pharma data analytics
Law Pharma data analytics
Conveying food innovations by health claims
Law Conveying food innovations by health claims
Medica 21 november 2013
Law Medica 21 november 2013
Legal and regulatory aspects of functional and medical foods
Law Legal and regulatory aspects of functional and medical foods
Novel foods and animal cloning era 5 may 2014
Business Novel foods and animal cloning era 5 may 2014
Patent Research Exemption and EU Tech Transfer Block Exemption Regulation arber gjunkshi
Law Patent Research Exemption and EU Tech Transfer Block Exemption Regulation arber gjunkshi
3d printing and biofabrication
Health & Medicine 3d printing and biofabrication
141023 novel foods for food expo
Food 141023 novel foods for food expo
Hacking Health Camp Strasbourg health data & data protection in the Netherlands
Law Hacking Health Camp Strasbourg health data & data protection in the Netherlands
Novel foods for Vitafoods
Law Novel foods for Vitafoods
Vitafoods Europe 2015: Clearer labels for consumers
Law Vitafoods Europe 2015: Clearer labels for consumers
Paperless Lab Academy 'legal aspects of big data analytics
Law Paperless Lab Academy 'legal aspects of big data analytics
B2B en B2C communicatie in de food sector
Food B2B en B2C communicatie in de food sector
Presentatie food seminar 24 juni 2015 (claudia bruins)
Food Presentatie food seminar 24 juni 2015 (claudia bruins)
Summer school Utrecht 3D printing and biofabrication
Law Summer school Utrecht 3D printing and biofabrication
Vitafoods B2C communication in the funtional food
Law Vitafoods B2C communication in the funtional food
Vitafoods - Alternative Sources of Protein
Law Vitafoods - Alternative Sources of Protein
Vitafoods marketing functional food to children
Law Vitafoods marketing functional food to children
Seminar General Data Protection Regulation
Law Seminar General Data Protection Regulation
Data protection and data integrity
Law Data protection and data integrity
Vitafoods eu clinical trials regulation
Law Vitafoods eu clinical trials regulation